Ru-catalysed domino hydroformylation/hydrogenation/esterification using imidazole ligands.

The present disclosure provides processes for preparing a crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile and related intermediate compounds.

A method for preparing a homogenous catalyst for the production of linear alpha olefins includes: preparing a first pre-catalyst solution comprising a modifier and an organoaluminum compound in a first solvent wherein the first pre-catalyst solution is reacted and stored in a first vessel for a period of time of 1 hour to 90 days; preparing a second pre-catalyst solution comprising a second solvent, a ligand, and a chromium containing compound, wherein the second pre-catalyst solution is stored in a second vessel for a period of time of 1 hour to 90 days; and after a period of time, adding the first pre-catalyst solution to a catalyst pre-formation unit; after the same period of time, adding the second pre-catalyst solution to the catalyst pre-formation unit; forming a homogenous catalyst by mixing the first pre-catalyst solution and the second pre-catalyst solution; adding the homogeneous catalyst to a reaction vessel, wherein the reaction vessel comprises an alpha olefin; and forming the linear alpha olefin by mixing the homogeneous catalyst and the homogenous catalyst.

Provided is an ionic solid having pores for incorporating a substance therein.

A process can be used for preparing aldehydes from C2 to C20 olefins with a subsequent thermal separation for removal of the aldehyde formed. The process involves a membrane separation, which is preceded by performance of a gas exchange by which the proportion of the partial pressure represented by carbon monoxide or hydrogen is increased in order to reduce catalyst losses.

A process for producing isomerized olefins, branched aldehydes and branched alcohols through isomerization, hydroformylation and hydrogenation.

Ru-catalysed domino hydroformylation/hydrogenation/esterification using imidazole ligands.

The present invention generally relates to processes for the recovery of rhodium from a catalyst purge stream from a C6 or higher olefin hydroformylation process. In one embodiment, the process comprises (a) treating a catalyst-containing liquid purge stream from the hydroformylation process, wherein the catalyst comprises a precious metal and an organophosphorous ligand, with an oxidant in the presence of a separate liquid aqueous phase comprising a halide-free acid at a sufficient temperature to effect oxidation of a majority of the contained organophosphorous ligand, wherein the halide-free acid is a C1-C6 organic acid or phosphorous acid; (b) recovering the aqueous phase; (c) contacting the aqueous phase with a separate organic phase by mixing the two phases under a syngas atmosphere, wherein the separate organic phase comprises water-insoluble, hydrolysable organophosphorous ligand and recycled olefin from a hydroformylation process; and (d) separating the organic phase to be recycled back to a hydroformylation process.

Provided are a 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based monophosphine ligand and intermediates thereof, and preparation methods and uses of the same. The monophosphine ligand is a compound represented by formula I or formula I′, or an enantiomer, a raceme or a diastereoisomer thereof, including phosphonite ligands, phosphite ligands, phosphoramidite ester ligands, phosphoric acid and phosphonic amide. The monophosphine ligand is prepared with a known 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-7,7′-diol derivative as a raw material through a scheme in which the compound presented by formula II acts as an intermediate. The present disclosure provides a novel monophosphine ligand, which can be used as a ligand in a metal-catalysed organic reactions or in directly catalyzing an organic reaction, especially as a chiral monophosphine ligand widely used in many chiral catalytic reactions such as asymmetric addition, asymmetric hydrogenation, asymmetric coupling, and asymmetric allyl alkylation, having economic practicality and industrial application prospects. ##STR00001##

The present disclosure provides processes for preparing a crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile and related intermediate compounds.